Please assess the completion status of the following clinical trial:

Trial Title: Study to Investigate the Clinical Benefits of Dietary Supplement Quercetin for Managing Early Mild Symptoms of COVID-19

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients must be 18 years of age or older, of either gender~* Patients must be tested positive for SARS-CoV-2 by RT-PCR~* Patients must exhibit typical symptoms of COVID-19 disease at screening such as fever, fatigue, a dry and contagious cough, loss of appetite, body aches, shortness of breath, mucus or phlegm, sore throat, headache, chills, sometimes with shaking, loss of smell or taste, congestion or runny nose, nausea, or vomiting, diarrhea, muscular pain etc.~* Patients must be in the early stage of COVID-19 disease who do not require hospitalisation at the time of screening~* Patients must be under the care of a Physician for diagnosis of COVID-19~* Patients who have signed informed consent~Exclusion Criteria:~* Patients with proven hypersensitivity or allergic reaction to quercetin~* Patients with known chronic kidney disease with estimated creatinine clearance \< 50 mL/minute or need for dialysis~* Patients who are severely hypotensive defined as needing hemodynamic pressors to maintain blood pressure~* Patients with moderate or severe thrombocytopenia (platelet count \<100 × 10⁹/L);~* Pregnant patients~* Patients declining to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard of care (SOC) (Type: ACTIVE_COMPARATOR): This arm will receive the standard of care (SOC) for COVID-19 as per the hospital guidelines.
- Quercetin (Type: EXPERIMENTAL): This arm will receive standard of care + oral Quercetin for two weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).